OFIX Stock Analysis: Buy, Sell, or Hold?
OFIX - Orthofix Medical Inc. Common Stock (DE)
$9.79
-0.20 (-2.00%)
▼
5d:
+4.37%
30d:
+6.88%
90d:
-17.73%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 03, 2026
10d
Get Alerted When OFIX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: OFIX shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: OFIX shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$6.51
Based on -2.9% avg growth
INTRINSIC VALUE TODAY
$4.04
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OFIX is currently trading at $9.79, which is considered extended relative to its 30-day fair value range of $8.98 to $9.65. From a valuation perspective, the stock is trading at a premium (Forward PE: 27.0) compared to its historical average (20.5). At these levels, the market is pricing in 9.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, OFIX is in a downtrend. The price is approaching resistance at $10.06. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: OFIX scores 38/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.00 (+30.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OFIX is in a downtrend. The price is approaching resistance at $10.06. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: OFIX scores 38/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.00 (+30.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$8.98 -
$9.65
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
27.6%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (38/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 30.1% below Wall St target ($13.00)
- NEUTRAL: Trading at premium valuation - market expects 9.5% growth which is achievable
- WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$8.98 -
$9.65
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$8.99
Resistance Level
$10.06
Current Trend
Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
27.00
Wall Street Target
$13.00
(+30.1%)
Revenue Growth (YoY)
3.8%
Profit Margin
-7.4%
Valuation Premium vs History
+9.5% premium
PE vs Historical
27.0 vs 20.5
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+9.5%
(market-implied from PE analysis)
1-Year Target
$10.94
(+10%)
2-Year Target
$11.98
(+20%)
3-Year Target
$13.12
(+31%)
3-Yr Target (if PE normalizes)
(PE: 27→21)
PE COMPRESSION
$9.96
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 27.0, Growth: -9.8%)
$7.34
(+-27%)
Base:
(SPY PE: 19.9, Growth: -9.8%)
$5.40
(-46%)
Bear:
(PE: 16.9, Growth: -9.8%)
$4.59
(-54%)
Share & Embed Analysis
Last updated: October 23, 2026 2:43 PM ET
Data refreshes hourly during market hours. Next update: 3:43 PM
Data refreshes hourly during market hours. Next update: 3:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OFIX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EW
Edwards Lifesciences Corp |
STRONG BUY
29 analysts |
$102 | 58 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 46 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$121 | 52 HOLD |
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$59 | 41 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 37 SELL |
